The Short Bowel Syndrome Market is expected to register a CAGR of 12.09% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Drug class (Glucagon-like Peptide, H2 Blockers, Proton Pump Inhibitors, Others); and Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Sales). The global analysis is broken down at the regional level and for major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Short Bowel Syndrome Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Short Bowel Syndrome Market Segmentation
Drug class- Glucagon-like Peptide
- H2 Blockers
- Proton Pump Inhibitors
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
Strategic Insights
Short Bowel Syndrome Market Growth Drivers- Rising Prevalence of Short Bowel Syndrome: The increasing prevalence of short bowel syndrome (SBS) is one of the primary growth drivers in this market. Short Bowel Syndrome cases are growing which drives this market development. The removal of a substantial part of the small intestine through surgery creates Short Bowel Syndrome which develops from Crohn's disease, ischemic bowel disease, or trauma. Advancements in surgery and more cases of underlying diseases have made SBS conditions appear more often. The number of SBS patients keeps increasing especially in North America and Europe because these regions have higher rates of intestinal disease surgeries. The need for SBS treatment methods like PN and enteral feeding grows because more patients survive intestinal surgeries but keep SBS. The number of SBS patients is increasing because medical teams now save more preterm infants who need intestinal surgery. Market expansion happens because people need more products to treat SBS symptoms such as drugs that improve gut function and devices for nutrient delivery. SBS therapy markets will grow worldwide in line with market projections that place this segment as a major contributor to total gastrointestinal therapeutic sales. The SBS market will grow and attract more patients for treatment because SBS cases keep increasing alongside healthcare efforts to help patients.
- Growing Number of Surgical Interventions: The rise in SBS cases is connected to better surgical techniques which save more of the digestive system. Surgical procedures used to treat Crohn's disease and other health problems like bowel resections and cancer can remove part of the small intestine which leads to SBS. The development of better medical tools and surgery methods lets doctors help more patients survive complex operations which then leads to more people developing SBS. SBS management solutions become more necessary due to rising numbers of patients who need surgery on their small intestine. People now survive surgical procedures for bowel obstruction and cancer better but their digestive system suffers which creates demand for treatment options that help them maintain proper nutrition and health. The market for SBS treatments that control nutrient absorption and gastrointestinal function grows because more patients develop this condition. Market projections show that growing surgery numbers will lead to more SBS patients in the future which will boost sales of SBS medical treatments. Companies that make enteral nutrition products and medical devices plus pharmaceuticals will see more business as the number of patients needing treatment grows.
- Increased Awareness and Early Diagnosis of SBS: The market for Short Bowel Syndrome treatments grows because healthcare providers now detect SBS sooner and patients know more about the disease. Healthcare teams have better recognized Short Bowel Syndrome through training which leads to earlier diagnosis. Detecting SBS early makes it possible to start effective treatment sooner which helps patients and lowers their chances of developing serious health problems. Advancements in medical technology and patient understanding now help doctors better detect and treat Short Bowel Syndrome compared to past years. Patients now recognize SBS better so they start getting medical help more often which creates more demand for treatments that help SBS patients live better. Improved medical diagnostics like CT scans MRI scans and specific blood tests will help doctors find SBS earlier which supports market growth. When patients learn more about SBS and treatment choices they will need more healthcare providers who focus on this condition. These elements including patient advocacy group efforts and healthcare organization outreach support market expansion. The SBS market will keep expanding as people gain more knowledge about this condition which drives demand for effective treatments.
- Growth of Home-Based Nutritional Support: One of the most significant trends in the Short Bowel Syndrome (SBS) market is the growing shift toward home-based nutritional support. More SBS patients now receive nutritional treatment in their own homes. Before recent changes SBS patients received their parenteral nutrition treatment in hospital settings. Patients now receive their nutrition care at home which lets them take charge of their diet. Medical technology has advanced to create pumps that patients can use at home plus better feeding tubes and nutritional treatments. Patients with chronic SBS need long-term nutrition support which this trend helps them access. Healthcare providers who move care to home settings need specialized nutrition products, medical tools, and prescription drugs designed for home use. Market predictions show healthcare systems and patients will benefit from this trend because patients want more control over their treatment and shorter hospital stays while saving money. The SBS market will expand mainly in countries with established home care programs that are shifting healthcare delivery from hospitals to personal homes. Companies developing SBS therapeutic solutions will find business opportunities from consumer demand for nutrition delivery systems and home treatment products.
- Personalized Medicine and Targeted Therapies: The Short Bowel Syndrome market will transform because doctors now use more precise medicine and treatment methods to help patients. Medical experts and scientists now use patient-specific genetic information and disease conditions to design better treatments for Short Bowel Syndrome. Medical research produces focused treatments like biologics that treat SBS's root causes. Through personalization healthcare providers can design better treatment plans that help patients recover faster with fewer side effects. Doctors are now using GLP-2 analogs to help patients with SBS restore their digestive system. Targeted medical treatments based on genetic research will become standard methods of treating SBS as medical technology advances. Personalized treatment plans will become standard care for SBS patients because patients need them. Predictions show personalized medicine will develop the SBS market further to offer better tailored treatments to patients.
- Integration of Artificial Intelligence (AI) in SBS Management: The integration of artificial intelligence (AI) and machine learning into the management of Short Bowel Syndrome is an emerging trend that could significantly transform the market. Companies use artificial intelligence systems to manage Short Bowel Syndrome treatments as a new market development. AI systems help doctors make better diagnoses of SBS patients while tracking their conditions and choosing the right treatments. AI systems review comprehensive patient data including genetic markers medical history and treatment reactions to guide healthcare providers in better treatment choices. AI systems can help doctors find patients who might get SBS problems and track the results of different medical treatments as they happen. AI systems can now create individualized care plans to achieve better results for SBS patients. The market will grow because healthcare providers use artificial intelligence to improve patient care and make their treatment processes more efficient. Market analysts predict AI integration will help doctors deliver better healthcare services to SBS patients while making their work more effective. Companies leading this market growth will develop artificial intelligence solutions for both SBS diagnosis and treatment enhancement.
- Expanding Global Access to Advanced Nutritional Solutions: An important growth opportunity in the Short Bowel Syndrome (SBS) market is the expansion of access to advanced nutritional solutions, particularly in emerging markets. The Short Bowel Syndrome market will grow through opening more markets to advanced nutritional treatments worldwide. The world sees more SBS patients emerge because of growing surgery numbers for Crohn's disease, cancer, and gastrointestinal injuries so better nutrition systems become essential. Nutritional therapy helps SBS patients get enough nutrients by giving them the calories and vitamins they need since their intestines cannot absorb them normally. Healthcare systems in developed markets use PN and enteral feeding tubes regularly to supply nutrition to SBS patients. Low-income and middle-income countries face difficulties getting these therapies because they cost too much and have poor healthcare systems. Companies should develop affordable solutions that work well in remote areas where medical care is limited. Healthcare providers and global health organizations are working to expand patient access while governments support this effort which creates more demand for affordable nutritional treatments. Market growth depends on creating portable feeders plus low-cost enteral nutrition products and home-friendly delivery systems. The rise of home medical care in areas with more healthcare education will boost market expansion. Medical companies and device makers who supply low-cost nutritious products to developing markets help grow the SBS market. Companies that focus their business on emerging markets with growing SBS rates can succeed in multiple markets while helping more patients worldwide.
- Technological Advancements in Intestinal Regeneration: The SBS market can expand through research and development of new intestinal restoration methods. Short Bowel Syndrome makes patients unable to absorb enough nutrients because their small intestine was severely damaged. Research in regenerative medicine shows that we can now develop better ways to heal or rebuild broken intestinal tissue. Scientists have advanced stem cell research as well as gene editing and tissue engineering techniques during the past ten years. Scientists discovered that stem cells can rebuild small intestinal tissue which offers new treatment possibilities for SBS patients. Technologies that help new intestinal cells grow better and make existing segments work better will reshape how doctors treat SBS patients. The development of GLP-2 analogs and other biologic therapies will drive medical progress forward in this field as companies lead the charge. The growing number of regenerative treatments for SBS expands treatment options which drives market prospects. New medical discoveries will help patients avoid long-term parenteral nutrition support and expensive treatments while making life better for them. The medical community and patient population will want more of these treatments because they are improving as research continues. The market expects regenerative treatments to grow more popular which will create new business potential in SBS treatment.
- Increasing Focus on Multidisciplinary Care Models: The market gains strength from expanding use of multidisciplinary teams to treat Short Bowel Syndrome patients. SBS patients need complete healthcare plans because they deal with nutrition problems plus fluid problems plus PN side effects. When healthcare experts from gastroenterology, nutrition, surgery, nursing and psychology work together they create personalized and integrated care for SBS patients. When multiple healthcare providers work together they help patients recover better and stay healthier while feeling better about their lives. More healthcare facilities now use a combined team approach to treat SBS patients because research proves it works better. The combined efforts of multiple healthcare disciplines help SBS patients avoid future treatment complications and follow their care plans better which saves money in the long run. More organizations will partner with healthcare providers to create personalized medical solutions which will bring new business possibilities to pharmaceutical companies medical device makers and nutrition product designers. The healthcare system now values integrated care more and will need better SBS management strategies because of this. Our industry will require better treatments for SBS patients that combine advanced nutrition support with therapy methods that aim to restore gut health and repair the body. Companies that deliver complete treatment plans to match these patient care models will succeed in the developing SBS market sector. The market growth for SBS treatments will increase as healthcare teams from different specialties work together to help patients.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Short Bowel Syndrome Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Short Bowel Syndrome Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Short Bowel Syndrome Market is estimated to witness a CAGR of 12.09% from 2025 to 2031.
The major factors driving the Short Bowel Syndrome Market are Rising Prevalence of Short Bowel Syndrome, Growing Number of Surgical Interventions, and Increased Awareness and Early Diagnosis of SBS.
Future trends in the Short Bowel Syndrome Market are the Growth of Home-Based Nutritional Support, Personalized Medicine and Targeted Therapies, and Integration of Artificial Intelligence (AI) in SBS Management.
Some of the players operating in the market are Takeda Pharmaceutical Company Limited, Zealand Pharma A/S, VectivBio AG, 9 Meters Biopharma, Inc, Hanmi Pharm.Co.,Ltd, GlaxoSmithKline, Plc, Cadila, Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Troikaa, AJANTA PHARMA.
The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.
Some customization options available based on the request are an additional 3–5 company profiles and a country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Short Bowel Syndrome Market - By Drug class
1.3.2 Short Bowel Syndrome Market - By Distribution channel
1.3.3 Short Bowel Syndrome Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SHORT BOWEL SYNDROME MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. SHORT BOWEL SYNDROME MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SHORT BOWEL SYNDROME MARKET - GLOBAL MARKET ANALYSIS
6.1. SHORT BOWEL SYNDROME - GLOBAL MARKET OVERVIEW
6.2. SHORT BOWEL SYNDROME - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SHORT BOWEL SYNDROME MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. GLUCAGON-LIKE PEPTIDE
7.3.1. Overview
7.3.2. Glucagon-like Peptide Market Forecast and Analysis
7.4. H2 BLOCKERS
7.4.1. Overview
7.4.2. H2 Blockers Market Forecast and Analysis
7.5. PROTON PUMP INHIBITORS
7.5.1. Overview
7.5.2. Proton Pump Inhibitors Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. SHORT BOWEL SYNDROME MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE SALES
8.5.1. Overview
8.5.2. Online Sales Market Forecast and Analysis
9. SHORT BOWEL SYNDROME MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Short Bowel Syndrome Market Overview
9.1.2 North America Short Bowel Syndrome Market Forecasts and Analysis
9.1.3 North America Short Bowel Syndrome Market Forecasts and Analysis - By Drug class
9.1.4 North America Short Bowel Syndrome Market Forecasts and Analysis - By Distribution channel
9.1.5 North America Short Bowel Syndrome Market Forecasts and Analysis - By Countries
9.1.5.1 United States Short Bowel Syndrome Market
9.1.5.1.1 United States Short Bowel Syndrome Market by Drug class
9.1.5.1.2 United States Short Bowel Syndrome Market by Distribution channel
9.1.5.2 Canada Short Bowel Syndrome Market
9.1.5.2.1 Canada Short Bowel Syndrome Market by Drug class
9.1.5.2.2 Canada Short Bowel Syndrome Market by Distribution channel
9.1.5.3 Mexico Short Bowel Syndrome Market
9.1.5.3.1 Mexico Short Bowel Syndrome Market by Drug class
9.1.5.3.2 Mexico Short Bowel Syndrome Market by Distribution channel
9.2. EUROPE
9.2.1 Europe Short Bowel Syndrome Market Overview
9.2.2 Europe Short Bowel Syndrome Market Forecasts and Analysis
9.2.3 Europe Short Bowel Syndrome Market Forecasts and Analysis - By Drug class
9.2.4 Europe Short Bowel Syndrome Market Forecasts and Analysis - By Distribution channel
9.2.5 Europe Short Bowel Syndrome Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Short Bowel Syndrome Market
9.2.5.1.1 Germany Short Bowel Syndrome Market by Drug class
9.2.5.1.2 Germany Short Bowel Syndrome Market by Distribution channel
9.2.5.2 France Short Bowel Syndrome Market
9.2.5.2.1 France Short Bowel Syndrome Market by Drug class
9.2.5.2.2 France Short Bowel Syndrome Market by Distribution channel
9.2.5.3 Italy Short Bowel Syndrome Market
9.2.5.3.1 Italy Short Bowel Syndrome Market by Drug class
9.2.5.3.2 Italy Short Bowel Syndrome Market by Distribution channel
9.2.5.4 Spain Short Bowel Syndrome Market
9.2.5.4.1 Spain Short Bowel Syndrome Market by Drug class
9.2.5.4.2 Spain Short Bowel Syndrome Market by Distribution channel
9.2.5.5 United Kingdom Short Bowel Syndrome Market
9.2.5.5.1 United Kingdom Short Bowel Syndrome Market by Drug class
9.2.5.5.2 United Kingdom Short Bowel Syndrome Market by Distribution channel
9.2.5.6 Rest of Europe Short Bowel Syndrome Market
9.2.5.6.1 Rest of Europe Short Bowel Syndrome Market by Drug class
9.2.5.6.2 Rest of Europe Short Bowel Syndrome Market by Distribution channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Short Bowel Syndrome Market Overview
9.3.2 Asia-Pacific Short Bowel Syndrome Market Forecasts and Analysis
9.3.3 Asia-Pacific Short Bowel Syndrome Market Forecasts and Analysis - By Drug class
9.3.4 Asia-Pacific Short Bowel Syndrome Market Forecasts and Analysis - By Distribution channel
9.3.5 Asia-Pacific Short Bowel Syndrome Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Short Bowel Syndrome Market
9.3.5.1.1 Australia Short Bowel Syndrome Market by Drug class
9.3.5.1.2 Australia Short Bowel Syndrome Market by Distribution channel
9.3.5.2 China Short Bowel Syndrome Market
9.3.5.2.1 China Short Bowel Syndrome Market by Drug class
9.3.5.2.2 China Short Bowel Syndrome Market by Distribution channel
9.3.5.3 India Short Bowel Syndrome Market
9.3.5.3.1 India Short Bowel Syndrome Market by Drug class
9.3.5.3.2 India Short Bowel Syndrome Market by Distribution channel
9.3.5.4 Japan Short Bowel Syndrome Market
9.3.5.4.1 Japan Short Bowel Syndrome Market by Drug class
9.3.5.4.2 Japan Short Bowel Syndrome Market by Distribution channel
9.3.5.5 South Korea Short Bowel Syndrome Market
9.3.5.5.1 South Korea Short Bowel Syndrome Market by Drug class
9.3.5.5.2 South Korea Short Bowel Syndrome Market by Distribution channel
9.3.5.6 Rest of Asia-Pacific Short Bowel Syndrome Market
9.3.5.6.1 Rest of Asia-Pacific Short Bowel Syndrome Market by Drug class
9.3.5.6.2 Rest of Asia-Pacific Short Bowel Syndrome Market by Distribution channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Short Bowel Syndrome Market Overview
9.4.2 Middle East and Africa Short Bowel Syndrome Market Forecasts and Analysis
9.4.3 Middle East and Africa Short Bowel Syndrome Market Forecasts and Analysis - By Drug class
9.4.4 Middle East and Africa Short Bowel Syndrome Market Forecasts and Analysis - By Distribution channel
9.4.5 Middle East and Africa Short Bowel Syndrome Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Short Bowel Syndrome Market
9.4.5.1.1 South Africa Short Bowel Syndrome Market by Drug class
9.4.5.1.2 South Africa Short Bowel Syndrome Market by Distribution channel
9.4.5.2 Saudi Arabia Short Bowel Syndrome Market
9.4.5.2.1 Saudi Arabia Short Bowel Syndrome Market by Drug class
9.4.5.2.2 Saudi Arabia Short Bowel Syndrome Market by Distribution channel
9.4.5.3 U.A.E Short Bowel Syndrome Market
9.4.5.3.1 U.A.E Short Bowel Syndrome Market by Drug class
9.4.5.3.2 U.A.E Short Bowel Syndrome Market by Distribution channel
9.4.5.4 Rest of Middle East and Africa Short Bowel Syndrome Market
9.4.5.4.1 Rest of Middle East and Africa Short Bowel Syndrome Market by Drug class
9.4.5.4.2 Rest of Middle East and Africa Short Bowel Syndrome Market by Distribution channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Short Bowel Syndrome Market Overview
9.5.2 South and Central America Short Bowel Syndrome Market Forecasts and Analysis
9.5.3 South and Central America Short Bowel Syndrome Market Forecasts and Analysis - By Drug class
9.5.4 South and Central America Short Bowel Syndrome Market Forecasts and Analysis - By Distribution channel
9.5.5 South and Central America Short Bowel Syndrome Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Short Bowel Syndrome Market
9.5.5.1.1 Brazil Short Bowel Syndrome Market by Drug class
9.5.5.1.2 Brazil Short Bowel Syndrome Market by Distribution channel
9.5.5.2 Argentina Short Bowel Syndrome Market
9.5.5.2.1 Argentina Short Bowel Syndrome Market by Drug class
9.5.5.2.2 Argentina Short Bowel Syndrome Market by Distribution channel
9.5.5.3 Rest of South and Central America Short Bowel Syndrome Market
9.5.5.3.1 Rest of South and Central America Short Bowel Syndrome Market by Drug class
9.5.5.3.2 Rest of South and Central America Short Bowel Syndrome Market by Distribution channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SHORT BOWEL SYNDROME MARKET, KEY COMPANY PROFILES
11.1. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ZEALAND PHARMA A/S
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. VECTIVBIO AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. 9 METERS BIOPHARMA, INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. HANMI PHARM.CO.,LTD
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GLAXOSMITHKLINE, PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CADILA PHARMACEUTICALS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SUN PHARMACEUTICAL INDUSTRIES LTD
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TROIKAA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. AJANTA PHARMA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1.Takeda Pharmaceutical Company Limited
2.Zealand Pharma A/S
3.VectivBio AG
4.9 Meters Biopharma, Inc
5.Hanmi Pharm.Co.,Ltd
6.GlaxoSmithKline, Plc
7.Cadila Pharmaceuticals
8.Sun Pharmaceutical Industries Ltd
9.Troikaa
10.AJANTA PHARMA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For